BioWorld MedTech

Aug. 6, 2012

View Archived Issues

Report from Europe: TFS implements Medidata's CTMS to expanding base

Washington roundup: NEJM's article on to-market times omits duration of trials

Agreements/contracts: Humana reports in-network access to Tenent subsidiaries

Deals roundup: Opko Health acquires Farmadiet Group Holding

Restructuring roundup: NeoGenomics to expand Fort Myers headquarters

People in the News

Financings roundup: Globus price Class A stock at $12 per share

Product Briefs

MDD's Neurology Extra

FDA clears ingestible sensor from Proteus for smart drugs

Proteus Digital Health (Redwood City, California) has received FDA clearance for its ingestible sensor technology for marketing as a medical device. Read More

DePuy Synthes gets FDA OK for scoliosis systems

Today's news in brief

BioWorld

BioWorld briefs for July 10, 2026.

3D rendering of an antibody drug conjugate

‘Target-high but uptake-defective’ state identified in ADC resistance

BioWorld

Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...

Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

BioWorld

News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...

FENS 2026: Shedding light on the sheddome

BioWorld

At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...

FENS 2026: Next-gen biologics take on brain disease

BioWorld

Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...